RESUMO
Metronidazole and its derivatives are widely used for the treatment of amoebiasis. However, metronidazole is considered as the standard drug but it has many side effects. The present study describes the synthesis of a series of metronidazole based thiazolidinone analogs via Knoevenagel condensation of 4-[2-(2-methyl-5-nitro-1H-imidazole-1-yl)ethoxy]benzaldehyde 1 with various thiazolidinone derivatives 2-14 to get the new scaffold (15-27) having better activity and lesser toxicity. Six compounds have shown better efficacy and lesser cytotoxicity than the standard drug metronidazole towards HM1: IMSS strain of Entamoeba histolytica. These compounds may combat the problem of drug resistance and might be effective in identifying potential alternatives for future drug discovery against EhOASS.
Assuntos
Amebicidas/farmacologia , Metronidazol/farmacologia , Tiazolidinas/farmacologia , Amebicidas/síntese química , Amebicidas/metabolismo , Amebicidas/toxicidade , Domínio Catalítico , Entamoeba histolytica/efeitos dos fármacos , Células HEK293 , Humanos , Metronidazol/síntese química , Metronidazol/metabolismo , Metronidazol/toxicidade , Simulação de Acoplamento Molecular , Estrutura Molecular , Testes de Sensibilidade Parasitária , Ligação Proteica , Proteínas de Protozoários/química , Proteínas de Protozoários/metabolismo , Relação Quantitativa Estrutura-Atividade , Sulfatases/química , Sulfatases/metabolismo , Tiazolidinas/síntese química , Tiazolidinas/metabolismo , Tiazolidinas/toxicidadeRESUMO
The evolution of voltage-gated calcium channel (Cav) in eukaryotes is an area of interest for biologists worldwide. The CLAN CL0030 and its family Ion_Trans 2 PF 07885 have been known to be present in prokaryotes, but the origin of these ion channels in Acanthamoeba spp. is yet to be determined. We inferred the origin of primitive forms of two-pore channels like proteins, human-like Cav 1.1 of L-type, and Cav subunit alpha-2/delta-1 in Acanthamoeba spp. early during evolution. By in-depth investigation into genomics, transcriptomics, use of bioinformatics tools and experimentations done with drugs like amlodipine and gabapentin on Acanthamoeba spp., we show the evidence of primitive forms of these channels in this protist pathogen. Genomics and transcriptomics of proteins ACA1_167020, 092610, and 270170 reflected their cellular expression in Acanthamoeba spp. We performed amino acid sequence homology, 3D structural modeling, ligand binding predictions, and dockings. Bioinformatics and 3D structural models show similarities between ACA1_167020, 092610, 270170, and different types of known human Cav. We show amoebicidal effects of amlodipine and gabapentin on Acanthamoeba spp., which can help design their structural analogs to target pathogenic genotypes of Acanthamoeba in diseases like Acanthamoeba keratitis and granulomatous amoebic encephalitis.
Assuntos
Acanthamoeba castellanii/metabolismo , Amebicidas/química , Bloqueadores dos Canais de Cálcio/química , Canais de Cálcio/metabolismo , Acanthamoeba castellanii/efeitos dos fármacos , Amebicidas/metabolismo , Amebicidas/farmacologia , Sequência de Aminoácidos , Anlodipino/química , Anlodipino/metabolismo , Anlodipino/farmacologia , Sítios de Ligação , Bloqueadores dos Canais de Cálcio/metabolismo , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/química , Anidrase Carbônica I/química , Anidrase Carbônica I/metabolismo , Gabapentina/química , Gabapentina/metabolismo , Gabapentina/farmacologia , Humanos , Ligação de Hidrogênio , Ligantes , Simulação de Acoplamento Molecular , Estrutura Terciária de Proteína , Alinhamento de SequênciaRESUMO
We report nanomicelles of amphotericin B (AmB) using various molar ratios of AmB and sodium deoxycholate sulfate (SDCS) for inhalation with improved stability, solubility, bioactivity, and safety. The particle sizes of all aerosolized formulations are expressed as mass median aerodynamic diameter (0.9-1.6 µm), fine particle fraction (70.3-86.5%), and geometric standard deviation (1.4-2.1) which indicated their sizes are appropriate for use as an inhaler. In vitro cytotoxicity studies conducted using respiratory and kidney cell lines demonstrated that the marketed Fungizone® was toxic to macrophage and embryonic kidney cells and cell viability decreased from 96 to 48% and from 97 to 67%, respectively when the AmB equivalent concentration was increased from 1 to 16 µg/mL. However, AmB-SDCS formulations showed no evidence of toxicity even up to 8 µg/mL compared to Fungizone®. Minimum inhibitory and fungicidal concentrations were significantly reduced against Cryptococcus neoformans, and Candida albicans. Also, antileishmanial activity significantly improved for AmB-SDCS formulations. There was an evidence of phagocytosis of the AmB-SDCS formulation by alveolar macrophages NR 8383. Molecular modeling studies suggested the role of hydrogen bonding in stabilization of the AmB-SDCS complex. This study indicated that AmB-SDCS nanomicelles can be used to design a safe and cost-effective AmB for inhalation. Graphical abstract á .
Assuntos
Anfotericina B/administração & dosagem , Sobrevivência Celular/efeitos dos fármacos , Ácido Desoxicólico/administração & dosagem , Portadores de Fármacos/administração & dosagem , Nanopartículas/administração & dosagem , Sulfatos/administração & dosagem , Células A549 , Aerossóis , Amebicidas/administração & dosagem , Amebicidas/metabolismo , Anfotericina B/metabolismo , Animais , Antibacterianos/administração & dosagem , Antibacterianos/metabolismo , Antifúngicos/administração & dosagem , Antifúngicos/metabolismo , Candida albicans/efeitos dos fármacos , Candida albicans/fisiologia , Sobrevivência Celular/fisiologia , Ácido Desoxicólico/metabolismo , Portadores de Fármacos/metabolismo , Células HEK293 , Humanos , Lipídeos , Micelas , Testes de Sensibilidade Microbiana , Nanopartículas/metabolismo , Tamanho da Partícula , Solubilidade , Sulfatos/metabolismoRESUMO
OBJECTIVE: The aim of the current study was to identify the human cytosolic sulfotransferases (SULTs) that are capable of sulfating clioquinol and iodoquinol, and to verify the presence of clioquinol/ iodoquinol-sulfating activity in human organ homogenates and cultured cells. METHOD: An established sulfotransferase assay was employed to analyze clioquinol/iodoquinolsulfating activity of thirteen known human SULTs, as well as cytosols of human kidney, liver, lung, and small intestine. Metabolic labeling with [35S]sulfate in the presence of different concentrations of clioquinol/iodoquinol was performed using cultured HepG2 human hepatoma cells and Caco-2 human colon carcinoma cells. RESULTS: A systematic analysis revealed that six of the thirteen known human SULTs, SULT1A1 SULT1A2, SULTA3, SULT1B1, SULT1C4, and SULT1E1 showed considerable clioquinol/ iodoquinol-sulfating activity. Kinetic parameters of the sulfation of clioquinol and iodoquinol by three SULTs, SULT1A1, SULT1A3, and SULT1C4, that showed the strongest clioquinol/iodoquinolsulfating activity were determined. Moreover, clioquinol/iodoquinol-sulfating activity was detected in the cytosol fractions of human liver, lung, kidney, and small intestine. Cultured HepG2 and Caco-2 cells were shown to be capable of sulfating clioquinol/iodoquinol under metabolic conditions. CONCLUSION: Collectively, these results provided a molecular basis underling the metabolism of clioquinol and iodoquinol through sulfation.
Assuntos
Clioquinol/metabolismo , Citosol/metabolismo , Iodoquinol/metabolismo , Sulfotransferases/metabolismo , Amebicidas/administração & dosagem , Amebicidas/metabolismo , Células CACO-2 , Clioquinol/administração & dosagem , Citosol/enzimologia , Relação Dose-Resposta a Droga , Células Hep G2 , Humanos , Iodoquinol/administração & dosagem , Sulfatos/metabolismoRESUMO
BACKGROUND: In the microbial ecosystem, microbes compete for space and nutrients. Consequently, some have developed the ability to kill or inhibit the growth of other competing microbes by producing antimicrobial substances. As the 'producer' species are generally immune to these substances, their compounds act on the competing microbial species and give the producer more space and access to nutrients for growth. Many currently used antibiotics were developed by exploiting this potential of certain microbes. FINDINGS: Here, the free-living amoeba, Acanthamoeba castellanii, was investigated for its antibacterial activity against representative Gram positive and Gram negative bacteria, while bacterial isolates were tested for their anti-amoebic properties. Conditioned medium from A. castellanii showed remarkable bactericidal properties against methicillin-resistant Staphylococcus aureus (MRSA) exhibiting almost 100% kill rate, but had limited effect against Acinetobacter sp., Pseudomonas aeruginosa and vancomycin-resistant Enterococcus faecalis (VRE). Similarly, the conditioned medium of E. coli K1 and Enterobacter sp., exhibited potent anti-Acanthamoebic effects in a concentration-dependent manner. Conditioned media of Acanthamoeba, E. coli K1 and Enterobacter sp. showed no cytotoxicity in vitro when tested against human brain microvascular endothelial cells. Active molecule/s in aforementioned amoebic and two bacterial conditioned media were 5 - 10 kDa, and <5 kDa respectively. CONCLUSIONS: A. castellanii conditioned medium showed potent bactericidal properties against MRSA. The active molecule(s) are heat- and pronase-resistant, and in the 5 to 10 kDa molecular mass range. Contrary to this, E. coli K1 and Enterobacter sp., conditioned medium showed anti-amoebic effects that are <5 kDa in molecular mass, suggestive of active metabolites.
Assuntos
Acanthamoeba/química , Amebicidas/farmacologia , Anti-Infecciosos/farmacologia , Bactérias/química , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Amebicidas/isolamento & purificação , Amebicidas/metabolismo , Anti-Infecciosos/isolamento & purificação , Anti-Infecciosos/metabolismo , Meios de Cultivo Condicionados , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Viabilidade MicrobianaRESUMO
The pharmacokinetic (PK) parameters of artesunate, artemether and their metabolites dihydroartemisinin (DHA) and dihydroartemisinin-glucuronide (DHA-glucuronide) were determined in sheep naturally infected with Fasciola hepatica. Sheep were treated either with artesunate (intramuscular (i.m.): 40 and 60 mg/kg) or artemether (i.m.: 40 and 160 mg/kg; oral: 80 mg/kg). Blood samples were withdrawn at selected time points post treatment and the artemisinins were quantified in plasma by liquid chromatography and tandem mass spectrometry (LC-MS/MS). The in vitro effect of the metabolites against F. hepatica was investigated using a phenotype-based assay and scanning electron microscopy (SEM). Following artesunate applications (40 and 60 mg/kg), comparable C(max) (maximal plasma concentration) and AUCs (area under the plasma concentration-time curve) were observed for artesunate (C(max): 8.4×10(3) and 9.4×10(3)ng/ml; AUC: 6.9×10(5) and 9.7×10(5) ng min/ml), DHA (C(max): both 2.4×10(3)ng/ml; AUC: 3.7×10(5) and 5.0×10(5) ng min/ml), and DHA-glucuronide (C(max): 1.7×10(4) and 1.6×10(4)ng/ml; AUC: 2.6×10(6) and 3.3×10(6) ng min/ml). Mean elimination half-lifes (t(1/2)) of artesunate, DHA and DHA-glucuronide ranged between 58 and 63 min, 94 and 113min, and 89 and 98 min, respectively. The i.m. oil-based drug formulation liberated artemether slowly and constant levels of artemether and its metabolites were observed during the entire sampling period (24 h). The AUCs of all analytes were significantly higher for the i.m. 160 mg/kg dose compared to i.m. 40 and oral 80 mg/kg doses (P=0.018). Mean C(max) of artemether (2126 and 426 ng/ml) and DHA-glucuronide (3477 and 1587 ng/ml) were higher following oral compared to i.m. (160 mg/kg) treatments (P>0.068), whereas C(max) of DHA was significantly higher following i.m. applications (P=0.0062). DHA rapidly reduced the viability of F. hepatica in vitro, whereas DHA-glucuronide showed no activity. SEM observations revealed only minor and focal tegumental alterations in few of the DHA treated worms. The calculated PK parameters reflect the anthelmintic activity of artesunate and artemether following different routes of application and will aid in the design of future studies with these drugs.
Assuntos
Artemisininas/uso terapêutico , Fasciola hepatica , Fasciolíase/veterinária , Doenças dos Ovinos/tratamento farmacológico , Amebicidas/metabolismo , Amebicidas/farmacocinética , Amebicidas/uso terapêutico , Animais , Anti-Helmínticos/metabolismo , Anti-Helmínticos/farmacocinética , Anti-Helmínticos/uso terapêutico , Área Sob a Curva , Artemeter , Artemisininas/metabolismo , Artemisininas/farmacocinética , Artesunato , Cromatografia Líquida , Relação Dose-Resposta a Droga , Fasciola hepatica/ultraestrutura , Fasciolíase/tratamento farmacológico , Fasciolíase/parasitologia , Meia-Vida , Microscopia Eletrônica de Varredura , Estrutura Molecular , Ovinos , Doenças dos Ovinos/parasitologia , Espectrometria de Massas em TandemRESUMO
Clioquinol, originally marketed as an oral intestinal amebicide, was widely used for multiple intestinal disorders. Its use as an oral agent was, however, discontinued because of its possible association with subacute myelo-optico-neuropathy or SMON. Meanwhile, its use for neurodegenerative diseases has recently been suggested. The metabolic fate of clioquinol, however, is poorly described. Since clioquinol is excreted as a sulfate in animals and humans, we have sought to identify a human sulfotransferase (SULT) responsible for the sulfation. We found that sulfating activities of human jejunal cytosols to clioquinol were well correlated with those to dopamine, a typical SULT1A3 substrate. Consistently, recombinant SULT1A3 showed the highest activity to clioquinol in vitro among the human SULTs examined. The S(50) value for the clioquinol sulfation by SULT1A3 was similar to the K(m) value for that by cytosols from human jejunum, where SULT1A3 is abundantly expressed. Moreover, clioquinol inhibited both human jejunal cytosol- and SULT1A3-mediated sulfations of dopamine in a dose-dependent manner, showing similar IC(50) values. These results suggest that SULT1A3, which is highly expressed in intestine but not in liver, is responsible for the clioquinol sulfation in humans, raising a possibility that orally administered clioquinol might inhibit dopamine sulfation in human intestines.
Assuntos
Amebicidas/metabolismo , Quelantes/metabolismo , Clioquinol/metabolismo , Citosol/metabolismo , Dopamina/metabolismo , Jejuno/metabolismo , Sulfotransferases/metabolismo , Adulto , Arilsulfotransferase , Feminino , Humanos , Isoenzimas/genética , Isoenzimas/metabolismo , Cinética , Masculino , Pessoa de Meia-Idade , Proteínas Recombinantes/metabolismo , Especificidade por Substrato , Sulfotransferases/genética , Adulto JovemRESUMO
OBJECTIVES: The intestinal stability of perorally administered drugs has so far been determined using simulated intestinal fluid containing porcine pancreatin (SIF/P), as human gastrointestinal fluids are in most cases not available. In this study the metabolism of six low molecular mass drugs in SIF/P was compared with that in freshly collected porcine intestinal juice and on excised porcine intestinal mucosa. METHODS: The drugs used were oseltamivir, atazanavir, diloxanide, diltiazem, cephalothin and cefoxitin. Metabolism studies were carried out by incubating each drug in the in-vitro models and by analysing the percentage of unmodified remaining drug at fixed time points. KEY FINDINGS: Three drugs showed higher degradation on porcine mucosa compared with that in SIF/P and for five compounds a significantly higher metabolism in collected porcine intestinal juice versus SIF/P was observed. Metabolism of diloxanide furoate in collected intestinal juice, for example, was 40-fold higher compared with SIF/P. Moreover, the involvement of different metabolic pathways in porcine mucosa and intestinal juice was observed for cephalothin, being metabolized to desacetylcephalothin and thienyl-acetylglycine, whereas these metabolites were not found in SIF/P. In addition, diltiazem solution (0.25% m/v) was found to be significantly degraded in intestinal juice whereas its metabolism in SIF/P was negligible. CONCLUSIONS: These findings demonstrated that the use of SIF/P for evaluation of presystemic drug metabolism could be highly misleading. Incubation of drugs in freshly collected porcine intestinal juice will likely lead to the improvement of the mimicry of body conditions to evaluate presystemic drug metabolism.
Assuntos
Amebicidas/metabolismo , Antibacterianos/metabolismo , Antivirais/metabolismo , Líquidos Corporais/metabolismo , Bloqueadores dos Canais de Cálcio/metabolismo , Mucosa Intestinal/metabolismo , Animais , Cromatografia Líquida de Alta Pressão , Estabilidade de Medicamentos , Esterases/metabolismo , Pancreatina/metabolismo , Peptídeo Hidrolases/metabolismo , Suínos , Fatores de TempoRESUMO
Infections with Giardia lamblia, Entamoeba histolytica, and Trichomonas vaginalis, which cause diarrhea, dysentery, and vaginitis, respectively, are each treated with metronidazole. Here we show that Giardia, Entamoeba, and Trichomonas have oxygen-insensitive nitroreductase (ntr) genes which are homologous to those genes that have nonsense mutations in metronidazole-resistant Helicobacter pylori isolates. Entamoeba and Trichomonas also have nim genes which are homologous to those genes expressed in metronidazole-resistant Bacteroides fragilis isolates. Recombinant Giardia, Entamoeba, and Trichomonas nitroreductases used NADH rather than the NADPH used by Helicobacter, and two recombinant Entamoeba nitroreductases increased the metronidazole sensitivity of transformed Escherichia coli strains. Conversely, the recombinant nitroimidazole reductases (NIMs) of Entamoeba and Trichmonas conferred very strong metronidazole resistance to transformed bacteria. The Ehntr1 gene of the genome project HM-1:IMSS strain of Entamoeba histolytica had a nonsense mutation, and the same nonsense mutation was present in 3 of 22 clinical isolates of Entamoeba. While ntr and nim mRNAs were variably expressed by cultured Entamoeba and Trichomonas isolates, there was no relationship to metronidazole sensitivity. We conclude that microaerophilic protists have bacterium-like enzymes capable of activating metronidazole (nitroreductases) and inactivating metronidazole (NIMs). While Entamoeba and Trichomonas displayed some of the changes (nonsense mutations and gene overexpression) associated with metronidazole resistance in bacteria, these changes did not confer metronidazole resistance to the microaerophilic protists examined here.
Assuntos
Amebicidas/metabolismo , Antiprotozoários/metabolismo , Antitricômonas/metabolismo , Entamoeba/enzimologia , Giardia/enzimologia , Metronidazol/metabolismo , Nitrorredutases/metabolismo , Trichomonas/enzimologia , Amebicidas/farmacologia , Sequência de Aminoácidos , Animais , Antiprotozoários/farmacologia , Antitricômonas/farmacologia , Bacteroides/genética , Biotransformação , Códon sem Sentido , Farmacorresistência Bacteriana/genética , Entamoeba/efeitos dos fármacos , Giardia/efeitos dos fármacos , Helicobacter/genética , Metronidazol/farmacologia , Dados de Sequência Molecular , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Trichomonas/efeitos dos fármacosRESUMO
Emetine is one of the two active ingredients of syrup of ipecac which is used medicinally as antiparasitic and emetic, however little is known about its genotoxic activity. The goal of this study was to determine whether and how emetine and/or its metabolites might produce mitotic recombination using the in vivo Drosophila w/w+ eye somatic assay. A standard strain (which expresses basal levels of cytochrome P450 enzymes) and an insecticide-resistant strain (which constitutively over-expresses P450 genes) were employed. The results showed that emetine and/or its metabolites are active in the assay and that the genotoxic potential is significantly influenced in the presence of higher than normal concentrations of P450.
Assuntos
Amebicidas/toxicidade , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Emetina/toxicidade , Células Híbridas/efeitos dos fármacos , Mutagênicos/toxicidade , Amebicidas/metabolismo , Animais , Sistema Enzimático do Citocromo P-450/genética , Relação Dose-Resposta a Droga , Drosophila melanogaster , Emetina/metabolismo , Testes de Mutagenicidade , Mutagênicos/metabolismoRESUMO
Metronidazole, a 5-nitroimidazole drug, has been the gold standard for several decades in the treatment of infections with microaerophilic protist parasites, including Entamoeba histolytica. For activation, the drug must be chemically reduced, but little is known about the targets of the active metabolites. Applying two-dimensional gel electrophoresis and mass spectrometry, we searched for protein targets in E. histolytica. Of all proteins visualized, only five were found to form adducts with metronidazole metabolites: thioredoxin, thioredoxin reductase, superoxide dismutase, purine nucleoside phosphorylase, and a previously unknown protein. Recombinant thioredoxin reductase carrying the modification displayed reduced enzymatic activity. In treated cells, essential non-protein thiols such as free cysteine were also affected by covalent adduct formation, their levels being drastically reduced. Accordingly, addition of cysteine allowed E. histolytica to survive in the presence of otherwise lethal metronidazole concentrations and reduced protein adduct formation. Finally, we discovered that thioredoxin reductase reduces metronidazole and other nitro compounds, suggesting a new model of metronidazole activation in E. histolytica with a central role for thioredoxin reductase. By reducing metronidazole, the enzyme renders itself and associated thiol-containing proteins vulnerable to adduct formation. Because thioredoxin reductase is a ubiquitous enzyme, similar processes could occur in other eukaryotic or prokaryotic organisms.
Assuntos
Amebicidas/metabolismo , Entamoeba histolytica/efeitos dos fármacos , Entamoeba histolytica/enzimologia , Metronidazol/metabolismo , Metronidazol/farmacologia , Tiorredoxina Dissulfeto Redutase/metabolismo , Amebicidas/química , Amebicidas/farmacologia , Amebicidas/uso terapêutico , Sequência de Aminoácidos , Animais , Células Cultivadas , Cisteína/química , Cisteína/metabolismo , Entamoeba histolytica/citologia , Entamebíase/tratamento farmacológico , Metronidazol/química , Metronidazol/uso terapêutico , Dados de Sequência Molecular , Nitroimidazóis/química , Nitroimidazóis/metabolismo , Oxirredução , Proteínas de Protozoários/química , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Compostos de Sulfidrila/química , Tiorredoxina Dissulfeto Redutase/química , Tiorredoxina Dissulfeto Redutase/genética , Tiorredoxinas/química , Tiorredoxinas/genética , Tiorredoxinas/metabolismoRESUMO
The activities of the N-(nitrothiazolyl) salicylamide nitazoxanide and its metabolite tizoxanide were compared with metronidazole in vitro in microplates against six axenic isolates of Giardia intestinalis. Tizoxanide was eight times more active than metronidazole against metronidazole-susceptible isolates and twice as active against a resistant isolate. In 10 axenic isolates of Entamoeba histolytica, while tizoxanide was almost twice as active as metronidazole against more susceptible isolates, it was more than twice as active against less susceptible isolates. Fourteen metronidazole-susceptible isolates of Trichomonas vaginalis were 1.5 times more susceptible to tizoxanide, which was nearly five times as active against resistant isolates. Two highly metronidazole-resistant isolates retained complete susceptibility to tizoxanide, and one moderately resistant isolate showed reduced susceptibility. In all three organisms, nitazoxanide results paralleled those of tizoxanide. Analogues lacking the reducible nitro-group had similar low activities against susceptible G. intestinalis, E. histolytica and T. vaginalis, indicating that nitro-reduction and free radical production was a probable mode of action. Nitazoxanide and its metabolite tizoxanide are more active in vitro than metronidazole against G. intestinalis, E. histolytica and T. vaginalis. Although, like metronidazole, they depend on the presence of a nitro-group for activity, they retain some activity against metronidazole-resistant strains, particularly of T. vaginalis. The results suggest that resistance mechanisms for metronidazole can be bypassed by nitazoxanide and tizoxanide.
Assuntos
Antiprotozoários/farmacologia , Entamoeba histolytica/efeitos dos fármacos , Giardia lamblia/efeitos dos fármacos , Tiazóis/farmacologia , Trichomonas vaginalis/efeitos dos fármacos , Amebicidas/química , Amebicidas/metabolismo , Amebicidas/farmacologia , Animais , Antiprotozoários/química , Antiprotozoários/metabolismo , Antitricômonas/química , Antitricômonas/metabolismo , Antitricômonas/farmacologia , Resistência Microbiana a Medicamentos/fisiologia , Entamoeba histolytica/isolamento & purificação , Giardia lamblia/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana/estatística & dados numéricos , Nitrocompostos , Relação Estrutura-Atividade , Tiazóis/química , Tiazóis/metabolismo , Trichomonas vaginalis/isolamento & purificaçãoRESUMO
Clioquinol is a hydroxyquinoline antibiotic that has been associated with severe side-effects in the CNS. The syndrome caused by clioquinol treatment, subacute myelo-optic neuropathy (SMON), is considered as one of the worst drug disasters of this century. The precise biochemical mechanism behind SMON is not fully understood. Clioquinol can form strong lipophilic chelates with divalent cations and therefore it has been speculated that the drug may disturb the retention of vitamin B(12) through chelation of Co(2+). In the present study, the tissue distribution and uptake capacity of [57Co]cyanocobalamin were estimated in mice treated with clioquinol or saline. The concentrations of some trace metals were also determined in brain tissue. Accumulation of vitamin B(12) in the brain and its concentration in blood were decreased by clioquinol treatment. The mean concentrations of several trace metals were also lowered in the brain while the concentration of cobalt in the brain was not affected, suggesting that clioquinol does not bind to the cobalt in vitamin B(12). Moreover, a significant decrease in the levels of S-adenosylmethionine (SAM) was observed in the brain after clioquinol treatment. This may be a consequence of decreased vitamin B(12) levels. From these results, it can be concluded that chronic treatment with clioquinol may alter the tissue homeostasis of vitamin B(12) in the brain.
Assuntos
Amebicidas/metabolismo , Encéfalo/metabolismo , Clioquinol/metabolismo , Metais/metabolismo , Oligoelementos/metabolismo , Vitamina B 12/metabolismo , Animais , Masculino , Camundongos , Camundongos Endogâmicos , Doenças do Nervo Óptico/metabolismo , S-Adenosil-Homocisteína/metabolismo , S-Adenosilmetionina/metabolismoRESUMO
Antagonism between Bacillus licheniformis M-4 and the pathogenic amoeba Naegleria fowleri HB-1 during cocultivation was influenced by the composition of the medium and the initial amoeba/bacterium ratio. While a ratio of 50 caused complete lysis of amoebae in soil extract with 0.3% glucose (SEG) before 72 h, this ratio had to be at least 12-fold lower in order to obtain similar results in Cline medium. Sporulation of B. licheniformis M-4 took place much earlier in SEG. Amoebicin production was stimulated by the presence of amoebae by either shortening the time of production (as in SEG) or increasing the amount of amoebicins released (as in Cline medium). Electron microscopy showed that amoebae cocultivated in the Cline medium contained bacteria enclosed in digestive vacuoles, while amoebae from SEG cocultures did not.
Assuntos
Amebicidas/metabolismo , Bacillus/metabolismo , Naegleria fowleri/microbiologia , Animais , Bacillus/crescimento & desenvolvimento , Bacillus/ultraestrutura , Microscopia Eletrônica , Naegleria fowleri/crescimento & desenvolvimento , Naegleria fowleri/ultraestruturaRESUMO
Three antibiotic peptides with amoebolytic activity have been purified from culture supernatants of Bacillus licheniformis M-4 (amoebicins m4-A, m4-B, and m4-C). They were hydrophilic peptides consisting of six different amino acids (Asp, Glu, Ser, Thr, Pro, Tyr). Their molecular weights ranged from 3,000 to 3,200. Purified amoebicins were active against human pathogenic and non-pathogenic strains of Naegleria. They also showed a broad antifungal spectrum, but a narrow antibacterial activity.
Assuntos
Amebicidas/isolamento & purificação , Bacillus/metabolismo , Peptídeos/isolamento & purificação , Amebicidas/química , Amebicidas/metabolismo , Amebicidas/farmacologia , Animais , Naegleria/efeitos dos fármacos , Naegleria/crescimento & desenvolvimento , Peptídeos/química , Peptídeos/metabolismo , Peptídeos/farmacologiaRESUMO
Free-living amoebae belonging to the species Naegleria fowleri are known to be the etiological agents for a form of fulminant meningoencephalitis that is generally fatal (primary amoebic meningoencephalitis). In a broad bacterial screening from soil and water we have isolated three strains (M-4, D-13 and A-12) belonging to the species Bacillus licheniformis that have remarkable amoebicidal activity against Naegleria sp. and also against different Gram-positive and Gram-negative bacteria. Physical-chemical characteristics, partial purification and biological activities of a substance produced by the M-4 strain have been investigated. This substance (m-4) is stable at high temperature (up to 100 degrees C) and extremes of pH (2.5-9.5) and also at -20 degrees C for months. Its production is greatly influenced by oxygenation of the cultures and is probably related to the sporulation process of the bacterium. Scanning electron microscope observations reveal that amoebae are lysed after a few minutes contact with m-4.
Assuntos
Bacillus/fisiologia , Naegleria fowleri/fisiologia , Amebicidas/metabolismo , Animais , Bacillus/isolamento & purificação , Bacillus/metabolismo , Naegleria fowleri/ultraestruturaRESUMO
Mutagenic N-nitroso compound formation from the in vitro reaction of amebicides and anthelmintic drugs, which are pyrimidine derivatives or contain secondary aliphatic amines or heterocyclic nitrogens, has been previously described (Arriaga Alba et al.: Environmental and Molecular Mutagenesis 12:65-73, 1988). Under similar conditions, antiparasitic drugs containing halogenated derivatives of tertiary amines or quaternary ammonium salts do not form mutagenic nitrosated compounds. In the present study the mutagenic activity of mouse urine was determined after oral administration of sodium nitrite and the two above-mentioned groups of drugs (pyrantel pamoate, chloroquine, piperazine and dehydroemetine/iodochlorhydroxyquin and bephenium hydroxynaphthoate, respectively). Results show that the simultaneous administration of piperazine or chloroquine with sodium nitrite produced urinary mutagens that appeared conjugated as glucuronides, whereas pyrantel pamoate and dehydroemetine in the presence of nitrite caused only slightly mutagenic urine. No mutagenic activity was detected in the urine of mice to which halogenated derivatives of tertiary amines (iodochlorhydroxyquin) or quaternary ammonium salts (bephenium hydroxynaphthoate) were administered together with nitrite.
Assuntos
Amebicidas/metabolismo , Anti-Helmínticos/metabolismo , Mutagênicos/metabolismo , Nitritos/metabolismo , Nitrito de Sódio/metabolismo , Animais , Cloroquina/metabolismo , Masculino , Camundongos , Piperazina , Piperazinas/metabolismo , Urina/análiseRESUMO
4 amebicides (chloroquine diphosphate, diiodohydroxyquin, iodochlorohydroxyquin and dehydroemetine) and 6 anthelmintics (bephenium hydroxynaphthoate, 4-hexylresorcinol, mebendazole, niclosamide, pyrantel pamoate and pyrvinium pamoate) were tested for mutagenicity in the Salmonella typhimurium microsomal test system. Frameshift mutations were induced by dehydroemetine and niclosamide following activation by microsomal enzymes, while pyrvinium pamoate induced both frameshift and base-pair substitution mutations with or without metabolic activation. The urine of mice treated with dehydroemetine or pyrvinium pamoate showed no mutagenic activity. However, urine obtained from mice treated with niclosamide was mutagenic in strains TA98 and TA1538. The fluctuation assay showed chloroquine diphosphate to be mutagenic in TA1537, a strain which detects frameshift mutations.
Assuntos
Amebicidas/toxicidade , Anti-Helmínticos/toxicidade , Mutagênicos , Mutação , Amebicidas/metabolismo , Amebicidas/urina , Animais , Anti-Helmínticos/metabolismo , Anti-Helmínticos/urina , Biotransformação , Camundongos , Microssomos Hepáticos/metabolismo , Testes de Mutagenicidade , Salmonella typhimurium/efeitos dos fármacosRESUMO
Problems posed by treatment of amoebiasis differ according to latitudes, safe immunologic reactions and technics of no invasive exploration allowed important progress, but diagnostic means are rarely disposable in Africa. Great progress of last ten years is owed to arrival of metronidazole and derivates under oral form and recently injectable. These therapeutics compose the base of treatment. In the first part, the author proposes a practice classification of different amoebicides in these groups; derivatives of the 5 nitro-imidazole, dehydroemetine, and other amoebicides. Structural characters, posology and the presentation of essential imidazole derivates are ouned up in a synoptic table. Pharmacokinetics characteristics, efficacy and secondary effects are studied afterwards. In a second part, indications and management are considered about means manifestations of amoebiasis.